Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001437749-25-020018
Filing Date
2025-06-10
Accepted
2025-06-10 21:30:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10810
  Complete submission text file 0001437749-25-020018.txt   12607
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Subject) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-89966 | Film No.: 251038655
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NORTHWEST REGISTERED AGENT 8735 DUNWOODY PLACE STE N ATLANTA GA 30350
Business Address
Ali Arif Nasir (Filed by) CIK: 0002072056 (see all company filings)

Type: SCHEDULE 13D/A